Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
Which stimulant is the prototype CNS stimulant?
|
Amphetamine
|
|
Amphetamines produce...?
|
mood elevation
increased wakefulness increased alertness increased concentration increased physical performance |
|
Amphetamines are a ___________ controlled drug.
|
Schedule II
High potential for abuse w/ severe liability for psychological and physical dependence. |
|
The anorexic effect of amphetamines and related sympathomimetic amines is due to...?
|
1. specific depressant effect on appetite (site of action is lateral hypothalamus)
2. psychological stimulation 3. increased energry expenditure due to physical activity and/or peripheral adrenergic receptor stimulation |
|
Amphetamine MOA?
|
1. indirect acting sympathomimetics
2. acts to release catecholamines (norepi and dopa) from their intraneural stores 3. acts to block monoamine reuptake, thus prolonging action of monoamines at the synapse |
|
Amphetamine adverse effects?
|
peripheral actions mediated through the release of catecholamines cause cardiovascular side effects:
1. increased systolic and diastolic bp 2. tachycardia |
|
Amphetamine acute toxicity?
|
**With i.v. use in particular
1. marked CNS stimulation 2. paranoid psychosis 3. hypertensive crisis, tachycardia, arrhythmias 4. hyperthermia 5. convulsions, coma 6. formication --> believe insects under skin; will try to cut them out |
|
Amphetamine chronic toxicity?
|
1. marked tolerance and psychological and physiological dependence
2. psychosis --> hallucinations, delusions of persecution, feelings of omnipotence |
|
Phentermine?
|
Amphetamine derivative
1. lower abuse potential than amphetamine 2. classified as Schedule IV controlled substances 3. same MOA as amphetamine 4. approved by FDA for short-term use in trtmt of obesity |
|
Monoamine reuptake inhibitor?
|
Sibutramine
|
|
Sibutramine MOA?
|
Blocks neuronal uptake of NE, 5-HT, and Dopa
|
|
Sibutramine metabolism?
|
metabolized to active metabolites via CYP3A4
|
|
Sibutramine side effects?
|
No CNS depression, abuse potential, drug dependence or valvular pathology
1. tachycardia 2. PVCs 3. HTN 4. headache 5. dry mouth 6. insomnia 7. constipation 8. short duration of sleep |
|
What "Schedule" category is Sibutramine?
|
Schedule IV (but not an amphetamine)
|
|
Dosing, use?
|
Once daily dosing; no tolerance to anorexiant effect
Approved by FDA for long-term use in obesity. |
|
Clinical presentation of ADHD in preschoolers?
|
1. excessive motor activity
2. difficulty paying attention 3. not listening 4. not responding to normal praise and punishment 5. aggression 6. "can't play alone" 7. "is into everything" |
|
Clinical presentation of ADHD in school-age children?
|
1. short attention span
2. distractibility 3. restlessness 4. poor impulse control 5. poor peer relations 6. aggression 7. poor socialization 8. learniing disabilities 9. academic underachievement 10. low self-esteem 11. low frustration tolerance |
|
Clinical presentation of ADHD in adolescents?
|
Similar to school-age children, but w/ less hyperactivity and greater likelihood of impulse control problems
-- substance abuse -- alcoholism -- recklessness School adjustment problems |
|
Clinical presentation of ADHD in adults?
|
1. short attention span
2. restlessness or fidgetiness 3. quick or excessive temper 4. poor impulse control 5. mood abnormalities 6. poor organization w/ inability to complete tasks 7. low stress tolerance |
|
AHDH treatment of choice?
|
Methylphenidate (Ritalin)
Therapeutic action referred to as "paradoxical" because they act to increase persistence, attentiveness and concentration, and decrease excessive motor activity in ADHD children |
|
Methylphenidate duration of action?
|
4-5 hours, so second dose usually required around noon in order to control behavior at school in afternoon
Give DRUG HOLIDAY on weekend and summer to allow linear growth |
|
Slow release methylphenidate?
|
Duration of action is 12h so lasts entire school day
1. Outer coat contains small, readily bioavb dose which rapidly achieves therapeutic conc 2. remainder of dose released at constant rate from reservoir inside hard shell of tablet |
|
Methylphenidate MOA?
|
1. release NE and DA from neurons
2. block the reuptake of these catecholamines into their neurons |
|
What other drug can be used in place of methylphenidate?
|
Atomoxetine (Strattera)
|
|
Atomoxetine MOA?
|
selective NE reuptake inhibitor
**Should NOT be administered w/ MAO inhibitor |
|
Atomexitine adverse effects?
|
CHILDREN:
-- headache -- aggression -- irritability ADULTS: -- palpitations -- insomnia -- urinary retention Required to carry "black box" warning label for increased risk of suicidal throughts among children and adolescents |
|
Characteristics of narcolepsy?
|
Recurrent, uncontrollable, sudden episodes of sleep under conditions normally not conducive to sleep.
Often accompanied by -- hallucinations -- cataplexy -- sleep paralysis |
|
Narcolepsy treatment?
|
Modafinil
New amphetamine substitute approved for use in narcolepsy Claimed to have fewer disadvantages (mood changes, insomnia, abuse potential) than amphetamine |
|
Modafinil adverse effects?
|
headache
nausea nervousness anxiety insomnia rarely reported: increased bp, tachycardia |
|
Describe apnea of prematurity.
|
All premature neonates, as well as most full-term neonates, have apnea --> pauses in their breathing pattern
PATHOLOGICAL APNEA: -- apnea exceeding 20sec duration OR -- apnea less than 20sec if accomp by bradycardia or oxygen desaturation Contributed to neuronal immaturity of the brain; tends to resolve |
|
Preferred apnea treatment in neonates?
|
Theophylline
|
|
Theophylline MOA?
|
1. inhibition of phosphodiesterases, thereby increasing intracellular cyclic AMP
2. direct effects on intracellular Ca++ concentration 3. antagonism of adenosine receptors |
|
Therapeutic action of theophylline in management of Apnea of Prematurity?
|
1. stimulate contraction of skeletal and diaphragmatic muscle
2. stimulate the central respiratory drive centers 3. increase ventilatory center's sensitivity to CO2 |
|
Theophylline can specifically...?
|
1. eliminate episodes of greater than 20 seconds
2. reduce the number of episodes of shorter duration |
|
Theophylline toxicity?
|
1. B/C rapid i.v. infusion can result in severe toxicity or sudden death, drug should be injected slowly over 20-40min period
2. plasma conc should be monitored during therapy Symptoms include: headache tachycardia severe restlessness nausea emesis abdominal pain Focal and generalized seizures can occur w/o prior signs of toxicity |